Hepatic growth effects of methylprednisolone, azathioprine, mycophenolic acid, and mizoribine by Azzarone, A et al.
>. i 
1993 BRIEF COMMUNICATIONS 
13. Wiekre CG. Norman DJ. Bennison A. Barry JM. Bennett WM. 
Postrenal transplant erythrocytOSis: a review of 53 patients. 
Kidney Int 1983: 23: 73l. 
14. Friman S. Nyberg G. Blohme l. Erythrocytosis after renal trans-
plant: treatment by removal of the native kidneys. Nephrol Dial 
Transplant 1990: 5: 969. 
15. Bakris GL. Sauter ER. Hus8ey JL. Fisher JW. Gaber AO. Winsett 
R. Effects of theophylline on erythropoietin production in normal 
subjects and in patients with erythrocytosi8 after renal trans-
plantation. N Engl J Med 1990: 323: 86. 
16. Gould AB. Goodman SA. Green D. An in vivo effect of renin on 
erythropoietin formation. Lab Invest 1973; 28: 719. 
17. Fried W. BI 
angiotensi 
Lab Clin l 
18. Bauer C. Kl 
erythropoi 
19. Curtis JJ. L 
of remove 
plantatioz 
Received 27 May 1992. 
Accepted 17 September 1992. 
HEPATIC GROWTH EFFECTS OF METHYLPREDNISOLONE. AZATHIOPRINE. MYCOPHENOLIC ACID, AND 
MIZORIBINE I 
Cyclosporine I eSA) and FK506 augment liver regeneration 
after partial hepatectomy in rats (1. 2), an effect that is not 
the consequence of immune modulation (3). In addition. both 
drugs increase the hepatocyte proliferative response in dogs 
that is characteristic after Eck fistula. and they also prevent 
the hepatocyte atrophy and organelle disruptIon that is caused 
by this operation (4). Substances causing these changes have 
been termed hepatotrophic. Rapamycin (RPM)! a third potent 
immunosuppressant. has opposite 1 antihepatotrophic) actions 
without evidence of inherent hepatocyte toxicity 15). 
A hypothesis that these growth control alterations are caused 
by altered signal transduction of the hepatocytes independent 
of immunologic pathways (4) has been supported by in vivo 
and in vitro experimentation (3), However. there is a paucity 
of information about the influence of other immunosuppressive 
drugs on growth and regeneration. Using in vivo (partial hep-
atectomy) and in vitro (tissue culture) rat models described 
elsewhere (2, 3. 5. 6), we have investigated the effect upon 
hepatocyte proliferation of methylprednisolone (MP). myco-
phenolic acid (YtPA). mizoribine (MZ). and azathioprine 
IAZA). 
In vivo experiments were performed with adult male inbred 
Fisher 344 rats weighing 180-200 g (Hilltop Lab Animals. 
Scottsdale. PAl. The rats were given standard rat laboratory 
diet and water ad libitum, and kept in a temperature and light-
controlled room \light 0730-19301. Immunosuppressive drugs 
were given preoperatively on days -3. -2. and -1. and as a 
tinal dose just after 70% hepatectomy. The operations were 
performed between 0900 and 1030 under light ether anesthesia 
(2, 5). Immediate resumption of food and drink made it unnec-
essary to provide parenteral fluid and electrolyte support. At 
24 hr after the hepatectomy when the rat liver regeneration 
response is at its peak. 185x104 Bq JH-thymidine was admin-
istered by intraperitoneal injection. followed 2 hr later by 
guillotine killing. Hepatic DNA was extracted and purified as 
previously described (2. 5). DNA content was measured with a 
standard of calf thymus DNA (Sigma. St. Louis). Mitotic 
indices were obtained in 3 animals in the groups 1. 3. 5, i and 
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9. and in 6 animals in the groups 2. 4. 6, 8 and 10 (Table 1) 
that were sacrificed at 33 hr. The liver specimens from these 
animals were formalin-fixed. stained with H&E. and examined 
for the percentage of mitoses. 
The in vivo experimental groups are summarized in Table 1. 
After partial hepatectomy, the contemporaneous vehicle con-
trols showed considerable variability from group to group (Fig. 
1). In control experiments. the highest DNA synthesis and 
mitotic rates were in control animals injected with saline (Table 
1. groups 1 and 3) whereas the lowest were in animals with 
drug vehicle containing CMC solvent alone (group 9) and CMC 
mixed with Tween and alcohol (group 5). This suggested a 
potential inhibitory effect of the CMC carrier and emphasized 
the need for concurrent controls for each test group. 
The only drug that significantly augmented regeneration 
relative to the controls was MP. P<O.Ol (Fig. 1). The only drug 
that significantly inhibited regeneration was MZ (P<O.Ol). The 
MZ inhibition was profound. reducing DNA synthesis >85% 
and the mitosis rate >70% (Fig. 1). MPA at a standard dose 
and AZA at low (1 mg/kg orall and high (6 mg/kg i.m.) doses 
were without effect on regeneration in the whole animal (Fig. 
U. 
In vitro experiments were performed with hepatocyte culture 
preparations made from the livers of the same strain of unal-
Group 
1 (n-S) 
2 (na 13l 
3 (n=8) 
4 (n=13) 
5 (n=8) 
6 (n==13) 
-; (n=8) 
TABLE 1. Conditions of in vivo experiments" 
Dose used 
Drup Img/kg/ Route Vehicle 
daHl 
MP 
MZ 20 
MPA 15 
1M 
1M 
1M 
1M 
PO 
PO 
Saline 
Saline 
Saline 
Saline 
0.5% CMC: 0.4% Tween 
0.9 alcohol in saline 
0.5% CMC; 0.4% tween 
0.9% alcohol in saline 
PO Olive oil 
8 (n=13) AZA PO Olive oil 
9 (n=8) 1M 1 % CMC in saline 
10 (n-13I AZA 6 1M 1 % CMC in saline 
• Methylprednisolone IMP) and mizoribine (MZl were disaolved in 
saline: mycophenolic acid (MP A 1 was dissolved in 0.5 % carboxymethvl-
cellulose ICMCl. 0.4% Tween and 0.9% alcohol in saline; azathiopnne 
(AZAl was mixed with olive oil or dissolved with 1% CMC in saline . 
Drug solutlOn8 were made daily for each dOll8 of each drug. 
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FIGURE 1. JH·thymidine incorporation and mitoses/lOOO hepato· 
cytes in 70% hepatectomized rats treated or not treated with methyl· 
prednisolone (MP), mycophenolic acid (MPA), mizoribine (MZ), and 
azathioprine (AZA). Drug doses are as shown in Table 1. Twenty·one 
animals were used for each drug: 8 rats were used as control and 13 
were treated with the drugs. Three rats of each control group and six 
of each experimental group were used for determinations of the number 
of mitoses. Bars are mean :t: SD. (*)P<O.OI (drug versus control). 
tered male rats (180 and 200 g). Hepatocytes were isolated with 
a previously standardized in situ two· step collagenase perfusion 
technique (3. 6). The hepatocytes were dispersed and washed 
twice with cold CA"''''·free perfusion buffer and resuspended in 
basal medium (MEM) supplemented with pyruvate (1 mM). 
proline to.26 mM), insulin (10-7 Ml. and 5% FCS. Cell number· 
w"as determined with a hepatocytometer. Viability was deter· 
mined by trypan blue exclusion. For drug testing, only prepa· 
rations with >95% viability were used. DNA content of the 
harvest cells was determined by a microfluorometric method 
(2, 5), and DNA synthesis was measured by the method of 
Michelopoulos et al. (7) and expressed as cpm/Ilg DNA. The 
hepatocytes were plated at a cell density of 2xI06/well in a 
Corning 35-mm tissue culture dish containing 1.5 ml medium 
and maintained at 37°C in a 5% CO2 atmosphere. In prelimi· 
nary viability studies in which the basal medium was enriched 
with insulin but not with EGF, the viability of these resting 
hepatocytes over the 48 hr following a 3-hr attachment was 
diminished only by azathioprine (Table 2). 
After a 3-hr attachment period in the definitive in vitro 
experiments, the medium was replaced with 1.5 ml basal me-
dium tMEMl, to which EGF no ng/ml) and insulin (10-7 M) 
were added. MPA was dissolved in DMSO. and the other 3 
immunosuppressive drugs tested were dissolved in alcohol and 
added in the concentrations shown in Figure 2. The minute 
quantities of DMSO or alcohol added to the medium (1 Ill/mi) 
were shown not to affect hepatocyte proliferation (data not 
TABLE 2. Viability, DNA concentration. and tranumina .. levels of 
hepatocytel in media enriched with immunOluppreuive drugs in the 
abNnce of EGF" 
24 br 48 br 
Viability DNA Viability DNA ALT 
percentap (",/diabl percentage (",/diab) tU/mll 
Control 95%' 3.2%0.2 96%3 3.3%0.2 5. 1::t 1 
MPA 10 "g/ml 94%3 3.3%0.3 96%' 3.3%0.2 4.1%0.6 
AZA 1 "g/ml 56%' 2.1%0.3 35±5 1. 7%0.3 16%3 
MZ l00ng/ml 95%6 3.1±0.2 95%9 3.3%0.2 4.5%0.7 
MP 10 "g/ml 9'%3 3.3%0.3 97±3 3.3%0.2 5.1%0.8 
• MPA: mycophenolic acid: AZA: azathioprine; MZ: mizoribine; MP: 
methylprednisolone. 
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FIGURE 2. Doses versus DNA synthesis response with MP, MPA. 
and MZ of cultured hepatocyte. (n=9 for all data points (3 experiments 
with triplicate determinations,. Mean :t: SD; (*)P<O.05; (")P<O.Ol. 
shown). During the last half of the 48-hr culture period. 3 Ilei 
lH·thymidine was added to the wells containing hepatocytes 
and MP. MPA. or MZ. MZ and MPA inhibited the DNA 
synthesis of the cultured hepatocytes while the MP caused a 
near doubling of thymidine incorporation (Fig. 2). 
These results and the previously reported ones with cyclo· 
sporine. FK506. and RPM provide a basis for further inquiry. 
They suggest a fundamental difference between the growth 
effects of cytotoxic agents (AZA, MPA. and MZ) versus previ· 
ously studied drugs like CsA. FK506. and RPM that are thought 
to act by altering signal transduction (8). The cytotoxic agents 
act by selectively inhibiting the synthesis of purine nucleotides 
(adenine or guanine), thereby reducing DNA synthesis of a 
variety of immunologic and other specialized cells. including 
hepatocytes. However. in the intact animal. the hepatocyte 
proliferative response of regeneration was not demonstrably 
affected by AZA or MPA. although it was drastically reduced 
by MZ. In contrast. the hepatocytes in vitro' were killed (AZA) 
or rendered nonproliferative (MPA and MZ). Whether the 
striking effect of MZ in both testing conditions was a high· 
dose phenomenon or has a more specific explanation could not 
be determined from our experiments. 
The in vivo results that we obtained with a 4-day course 
before hepatectomy of either 1 or 6 mg/kg/day of azathioprine 
were remarkedly different than those reported by Kim et a1. 
(9) who observed striking augmentation of DNA synthesis in 
essentially the same experiments. They interpreted this as 
evidence that hepatic regeneration is immune-modulated. Be-
... 
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cause of the possibility that Kim (9) might have interposed a 
delay between the last drug dose and the partial hepatectomy, 
thereby allowing the beginning of regeneration in response to 
a chemical injury, we performed more experiments in which 
the last azathioprine dose was not given at the time of opera-
tion. Although the animals with the premature cessation of 
AZA treatment tended to have more vigorous regeneration 
\ Table 3), this difference was not statistically significant. How-
ever. the possibility of a "timing" artefact has not been ruled 
out and will require further study. 
Unlike AZA and the other cytotoxic drugs (MPA and MZ), 
~m caused a striking increase of proliferation of hepatocytes 
in culture and it augmented liver regeneration in the intact 
animal. Such steroid-stimulating effects on hepatocyte division 
have not been noted before-and. in fact, Richman et a1. (10) 
reported inhibition by dexamethasone. which in our model also 
was stimulatory (unpublished observations l. MP is known to 
inhibit the synthesis and expression of multiple cytokines 
including ILl, IL./, and migration inhibitor factor \ 11. 12l. 
Although ILl and ILl are thought from reported in vitro exper-
iments to be growth suppressors \ 13) this could not be dem-
onstrated by us in a sensitive in vivo test system in which the 
recombinant cytokines in question were infused directly into 
the tied-off portal vein of the Eck tistula liver 114). Thus. the 
proliferative response to MP reported herein both in vivo and 
in vitro cannot be explained by what is currently known about 
steroid actions. 
In contrast. the inhibition of hepatocyte proliferation by 
cytotoxic drugs is consistent with previous reports about AZA 
(15). A seemingly obvious explanation could be that AZA. 
MPA. and MZ selectively inhibit synthesis of purine nucleo-
tides (adenine with AZA and guanine with MPA and MZ) that 
are required for DNA synthesis. 
The molecular basis of growth alterations by immunosup-
pressants is best understood with FK506. esA. and RPM-
drugs that alter signal transduction with pleiotropic effects not 
limited to Immune cells (3. 8). These agents. which are not 
inherently cytotoxic. are inactive "prodrugs" until they bind 
with ubiquitous cytosolic immunophilins and form complexes 
that act upon a common target\s) (8l. Although these molecular 
mechamsms have been determined principally with the lym-
phocyte and mast cell, the hepatocyte may be the best to 
investigate growth control (6). 
.\s the search continues for immunosuppressive drugs, it is 
self-evident that growth control qualities should be systemati-
cally determined. Conversely, drugs under study primarily for 
their hepatocyte growth control activity (14) should also be 
screened for possible immunosuppressive activity. 
TABLE :3. Effects on hepatocyte proliferation ot' AZA administration 
( ~roup n Operation .... ZA adminIstration Route cpmlmg DNA 
,) Sham 1.5 mgl kg for 3 davs PO 4.47i±4:20 
., K~ 70% PH 1.5 mg/kg for 3 days PO 87.574±18.315 
'; -;'0% PH 1.5 mgl kg for 4 days PO 55.318±15.422 
. Croups 1 and :2 were treated for 3 days but did not receive AZA on 
the dav of the operation as In our experiments shown In Figure 1 (group 
:l in this table). 
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